GIVETTE SALAZAR: Open Payments
NPI 1912153073 · MIRAMAR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 71 payments from 14 companies in 2025. Trend: 2023 $1,504 · 2024 $1,164 · 2025 $1,487
Food & beverage: $1,487
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 15 | $350 |
| ABBVIE INC. | 10 | $241 |
| PFIZER INC. | 10 | $239 |
| GlaxoSmithKline, LLC. | 15 | $206 |
| Astellas Pharma US Inc | 5 | $108 |
| Caris MPI, Inc. | 5 | $102 |
| Myriad Genetic Laboratories, Inc. | 3 | $64 |
| Verastem, Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $28 |
Products named: ELAHERE, TIVDAK, KEYTRUDA, JEMPERLI, LYNPARZA, Veozah, MI CANCER SEEK, MYRISK.
Industry payments across FL — which companies pay providers there.
